Search Results for "Flamel Technologies Stock Information"
Original Source: Flamel Technologies S.A.
Flamel Technologies is a drug delivery company with two intellectual property platforms: Micropump, for the controlled release of drugs best absorbed in the small intestine; and Medusa, for the controlled release of proteins, peptides, and other molecules injected subcutaneously or administered intravenously. Both of these platforms offer potential advantages with respect to efficacy and the reduction of side-effects, in addition to the obvious benefits assoc...
Matching Channels
Health IT Information Technology
Why Health IT? Health information technology (Health IT) makes it possible for health care providers to better manage patient care through secure use and sharing of health information - e...
Health IT (Information Technology) jobs
The Middle East has a wealth of biotechnology companies and is an important player in the global biotechnology industry. Following a World Summit on the Information Society, Arab countries are str...
Chronic leukemia is a long term increase of abnormal white blood cells. It can be classed as myelogenous or lymphocytic leukemia. For more information see the Leukemia pages Add the Leukemia New...
Self-management is quite a new idea in healthcare, and it is for patient with long-term conditions to regain some control over their life, and to be able lead a better life, despite their heal...
Matching News
Deerfield Announces Financing Transaction with Flamel Technologies
Deerfield Management Company announced that it had closed a transaction with Flamel Technologies (NASDAQ: FLML) and two of Flamel’s subsidiaries to provide $15 million. The obje...
[Flamel Technologies] nets $14.5mm in debt financing from Deerfield
Small- and large-molecule drug delivery firm [Flamel Technologies SA] (French-based company that trades on Nasdaq) and two of its subsidiaries have netted $14.5mm by selling nonconvertible notes to tw...
[Flamel] acquires Deerfield’s [Eclat Pharmaceuticals]
French Nasdaq-traded specialty pharmaceutical firm [Flamel Technologies SA] (drug delivery) has acquired Deerfield Capital’s privately held [Eclat Pharmaceuticals LLC], a US-based spec pharma focuse...
Flamel Shares Rise After Lawsuit Tossed Out
From Associated Press (March 22, 2013) NEW YORK -- Shares of Flamel Technologies SA rose Friday on news that a judge dismissed a class action suit against the French pharmaceutical company. Flamel sai...
LYON, FRANCE -- (Marketwire) -- 02/07/13 -- Flamel Technologies (NASDAQ: FLML) today announced that it has completed a USD$15 million debt financing with Deerfield Management, a current Flamel shar...
Flamel Technologies' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Flamel Technologies S.A. (FLML) Q1 2013 Earnings Call May 7, 2013 8:30 am ET Executives Bob Yedid – Investor Relations Michael S. Anderson – Chief Executive Officer Sian Crouzet – Princip...
LYON, FRANCE -- (Marketwire) -- 11/05/12 -- Flamel Technologies (NASDAQ: FLML) today announced its financial results for the third quarter of 2012. Highlights from the quarter and subsequent period...
LYON, FRANCE -- (Marketwired) -- 05/07/13 -- Flamel Technologies (NASDAQ: FLML) today announced its financial results for the first quarter of 2013. Highlights from the quarter and subsequent perio...
Matching PubMed Articles
Quantifying wikipedia usage patterns before stock market moves.
Financial crises result from a catastrophic combination of actions. Vast stock market datasets offer us a window into some of the actions that have led to these crises. Here, we investigate whether da...
Outlook of the world steel cycle based on the stock and flow dynamics.
We present a comprehensive analysis of steel use in the future compiled using dynamic material flow analysis (MFA). A dynamic MFA for 42 countries depicted the global in-use stock and flow up to the e...
Spawning stock and recruitment in North Sea cod shaped by food and climate.
In order to provide better fisheries management and conservation decisions, there is a need to discern the underlying relationship between the spawning stock and recruitment of marine fishes, a relati...
Company stock prices before and after public announcements related to oncology drugs.
Background Phase III clinical trials and Food and Drug Administration (FDA) regulatory decisions are critical for success of new drugs and can influence a company's market valuation. Knowledge of tria...
Presence of Infectious RD-114 Virus in a Proportion of Canine Parvovirus Isolates.
We recently found that certain canine live attenuated vaccines produced using 'non-feline' cell lines were contaminated with an infectious feline endogenous retrovirus, termed RD-114 virus. We suspect...
